Ownership Submission
FORM 3
 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Expires: January 31, 2005
Estimated average burden hours per response... 0.5

(Print or Type Responses)
1. Name and Address of Reporting Person *
  Bunge LTD
 2. Date of Event Requiring Statement (Month/Day/Year)
04/29/2011		 3. Issuer Name and Ticker or Trading Symbol
Renewable Energy Group, Inc. [REGI]
(Last)
(First)
(Middle)
50 MAIN STREET		 4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director __X__ 10% Owner
_____ Officer (give title below) _____ Other (specify below)
5. If Amendment, Date Original Filed(Month/Day/Year)
04/29/2011
(Street)

WHITE PLAINS, NY 10606		 6. Individual or Joint/Group Filing(Check Applicable Line)
___ Form filed by One Reporting Person
_X_ Form filed by More than One Reporting Person
(City)
(State)
(Zip)
Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)		 2. Amount of Securities Beneficially Owned
(Instr. 4)		 3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)		 4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Common Stock 497,611 (1) (2)
I
By Bunge North America, Inc. (1)

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. SEC 1473 (7-02)
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 4)		 2. Date Exercisable and Expiration Date
(Month/Day/Year)		 3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)		 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)		 6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares

Reporting Owners

Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
Bunge LTD
50 MAIN STREET
WHITE PLAINS, NY 10606		     X    
Bunge North America, Inc.
11720 BORMAN DRIVE
ST. LOUIS, MO 63146		     X    

Signatures

Bunge Limited, /s/ Carla Heiss 01/26/2012
**Signature of Reporting Person Date
Bunge North America, Inc., /s/ Eric Hakmiller 01/26/2012
**Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 5(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) The original filing erroneously reported ownership of 439,668 shares of Common Stock indirectly through Biofuels Company of America, LLC ("BCA"). The correct number of shares owned was 497,611. Bunge North America, Inc. owned a 22.2% ownership interest in BCA. Since the date of the original filing, BCA has distributed the shares to Bunge North America, Inc., who now owns the shares directly. Bunge North America, Inc. is a wholly-owned subsidiary of Bunge Limited.
(2) The amount of shares beneficially owned includes ownership of 9,708 Restricted Stock Units owned indirectly through Bunge North America, Inc., which is a wholly-owned subsidiary of Bunge Limited. The original filing erroneously failed to include these Restricted Stock Units, which will automatically convert into shares of Common Stock upon vesting. As of the date of this Form 3, all of the Restricted Stock Units remain unvested. The Restricted Stock Units will vest in full on the earliest of (i) August 18, 2013, (ii) a change of control of the issuer, (iii) the first date that Bunge North America, Inc. may sell Common Stock on The Nasdaq Global Market or on another national securities exchange without restriction, and (iv) the first three-month period following the development of a regular trading market with at least one market maker where trading volume during such three-month period is greater than 1% of the outstanding shares of Common Stock.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.